WMA
ABMD

Wealth Management Associates’s Abiomed Inc ABMD Stock Holding History

Wealth Management Associates’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-880
Closed -$316K – 205
2021
Q4 		$316K Buy
880
+26
+3% +$8.78K 0.17% 152
2021
Q3 		$278K Hold
854
– – 0.16% 143
2021
Q2 		$267K Hold
854
– – 0.15% 159
2021
Q1 		$272K Sell
854
-108
-11% -$34.6K 0.17% 140
2020
Q4 		$312K Buy
962
+234
+32% +$64.7K 0.2% 122
2020
Q3 		$202K Buy
+728
New +$210K 0.16% 151

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wealth Management Associates's ABMD Position: Q1 2022 in Review

Wealth Management Associates sold out of Abiomed Inc (ABMD) in Q1 2022, closing a stake of 880 shares — an estimated $316K sold.

Wealth Management Associates first reported a position in ABMD in Q3 2020 and held it in 6 quarters. The position peaked at $316K in Q4 2021. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

  • Wealth Management Associates reported no remaining Abiomed Inc position as of Q1 2022 after selling out during the quarter.
  • Wealth Management Associates sold 880 Abiomed Inc shares in Q1 2022, an estimated $316K.
  • Wealth Management Associates first reported a position in Abiomed Inc in Q3 2020 and held it in 6 quarters.
  • Wealth Management Associates's Abiomed Inc position peaked at $316K in Q4 2021.
  • 500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on Wealth Management Associates's 13F filing for Q1 2022, filed 28 May 2025.